12:00 CET

Presentation of the Q2 Interim Report 2021

Oncopeptides will publish its report for the second quarter 2021 on August 19, 2021, and will host a webcast on the same day at 12:00 CEST. 

Investors, financial analysts and media are invited to participate in this webcast with a QnA session.

The event will be hosted by CEO, Marty J Duvall and members of the Oncopeptides’ Leadership team. The presentation will be held in English. 

The webcast will be streamed via this link:
https://tv.streamfabriken.com/oncopeptides-q2-2021.


Phone numbers for participants:

Sweden: +46 8 566 426 51  PIN: 51415302#

Europe: +44 3333 000 804  PIN: 51415302#

USA: +1 8558570686  PIN: 51415302#

Upcoming events

Silent Period

-

FDA - Oncologic Drugs Advisory Committee (ODAC) Meeting

The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.

Interim Report Q3 2021

08:00 CET

Silent Period

-

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-